TDM of Generic Lopinavir/Ritonavir 200/50 mg

NCT00802334 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The HIV Netherlands Australia Thailand Research Collaboration

Collaborators